NMT1 (N-myristoyltransferase 1).
作者信息
Selvakumar Ponniah, Kumar Sujeet, Dimmock Jonathan R, Sharma Rajendra K
机构信息
Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N OW8, Canada (PS, SK, RKS); Cancer Research Unit, Saskatchewan Cancer Agency, 20 Campus Drive, Saskatoon, SK S7N 4H4, Canada (PS, SK, RKS); Drug Design and Discovery Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5C9, Canada (JRD).
出版信息
Atlas Genet Cytogenet Oncol Haematol. 2011 Jan 7;15(7):570-575. doi: 10.4267/2042/45997.
Abstract
摘要
相似文献
1
NMT1 (N-myristoyltransferase 1).
Atlas Genet Cytogenet Oncol Haematol. 2011 Jan 7;15(7):570-575. doi: 10.4267/2042/45997.
2
Inhibition of N-myristoyltransferase activity promotes androgen receptor degradation in prostate cancer.
Prostate. 2024 Feb;84(3):254-268. doi: 10.1002/pros.24645. Epub 2023 Oct 31.
3
The role of N-myristoyltransferase 1 in tumour development.
Ann Med. 2023 Dec;55(1):1422-1430. doi: 10.1080/07853890.2023.2193425.
4
N-Myristoyltransferase 1 enhances human immunodeficiency virus replication through regulation of viral RNA expression level.
Biochem Biophys Res Commun. 2015 Aug 7;463(4):988-93. doi: 10.1016/j.bbrc.2015.06.047. Epub 2015 Jun 11.
5
N-myristoyltransferase 1 is essential in early mouse development.
J Biol Chem. 2005 May 13;280(19):18990-5. doi: 10.1074/jbc.M412917200. Epub 2005 Mar 7.
6
N-Myristoyltransferase isozymes exhibit differential specificity for human immunodeficiency virus type 1 Gag and Nef.
J Gen Virol. 2008 Jan;89(Pt 1):288-296. doi: 10.1099/vir.0.83412-0.
7
N-myristoyltransferase-1 is necessary for lysosomal degradation and mTORC1 activation in cancer cells.
Sci Rep. 2020 Jul 20;10(1):11952. doi: 10.1038/s41598-020-68615-w.
8
SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway.
Can J Gastroenterol Hepatol. 2023 Mar 17;2023:2021515. doi: 10.1155/2023/2021515. eCollection 2023.
9
N-myristoyltransferase-1 deficiency blocks myristoylation of LAMTOR1 and inhibits bladder cancer progression.
Cancer Lett. 2022 Mar 31;529:126-138. doi: 10.1016/j.canlet.2022.01.001. Epub 2022 Jan 6.
10
NMT1 sustains ICAM-1 to modulate adhesion and migration of tumor cells.
Cell Signal. 2023 Sep;109:110739. doi: 10.1016/j.cellsig.2023.110739. Epub 2023 Jun 1.
引用本文的文献
1
Structure of Plasmodium vivaxN-myristoyltransferase with inhibitor IMP-1088: exploring an NMT inhibitor for antimalarial therapy.
Acta Crystallogr F Struct Biol Commun. 2025 Jan 1;81(Pt 1):1-10. doi: 10.1107/S2053230X24011348.
2
Ternary structure of Plasmodium vivaxN-myristoyltransferase with myristoyl-CoA and inhibitor IMP-0001173.
Acta Crystallogr F Struct Biol Commun. 2024 Oct 1;80(Pt 10):269-277. doi: 10.1107/S2053230X24008604. Epub 2024 Sep 18.
3
Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition.
J Transl Med. 2024 May 7;22(1):431. doi: 10.1186/s12967-024-05150-6.
4
Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression.
Signal Transduct Target Ther. 2023 Jan 9;8(1):14. doi: 10.1038/s41392-022-01248-9.
5
Structure and Functional Diversity of GCN5-Related N-Acetyltransferases (GNAT).
Int J Mol Sci. 2016 Jun 28;17(7):1018. doi: 10.3390/ijms17071018.
本文引用的文献
1
The potential use of N-myristoyltransferase as a biomarker in the early diagnosis of colon cancer.
Cancers (Basel). 2011 Mar 16;3(1):1372-82. doi: 10.3390/cancers3011372.
2
Myristoylation and membrane binding regulate c-Src stability and kinase activity.
Mol Cell Biol. 2010 Sep;30(17):4094-107. doi: 10.1128/MCB.00246-10. Epub 2010 Jun 28.
3
The chemical toolbox for monitoring protein fatty acylation and prenylation.
Nat Chem Biol. 2010 Jul;6(7):498-506. doi: 10.1038/nchembio.388.
4
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review.
Clin Ther. 2010 Mar;32(3):437-53. doi: 10.1016/j.clinthera.2010.03.012.
5
Protein myristoylation in health and disease.
J Chem Biol. 2010 Mar;3(1):19-35. doi: 10.1007/s12154-009-0032-8. Epub 2009 Nov 7.
6
Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007.
7
Evolving treatment of advanced colon cancer.
Annu Rev Med. 2009;60:207-19. doi: 10.1146/annurev.med.60.041807.132435.
8
Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells.
J Pathol. 2009 Jul;218(3):391-8. doi: 10.1002/path.2550.
9
Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo.
Clin Cancer Res. 2008 Sep 15;14(18):5743-8. doi: 10.1158/1078-0432.CCR-08-0405.
10
A quantitative atlas of mitotic phosphorylation.
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31.
Zotero 插件